What is it about?
This work describe the potentials of Oncolytic NDV Iraqi isolate as leukemia and lymphoma therapy
Featured Image
Why is it important?
It describe novel combination to treat cancer
Perspectives
This work is first step to develop this kind of therapy
Professor Ahmed Majeed Al-Shammari
Mustansiriyah University, Iraqi Cener for Cancer and Medical Genetic Research
Read the Original
This page is a summary of: Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy, Oncolytic Virotherapy, April 2016, Dove Medical Press,
DOI: 10.2147/ov.s95250.
You can read the full text:
Contributors
The following have contributed to this page
